Octreotide Compared With Placebo in a Treatment Strategy for Early Rebleeding in Cirrhosis. A Double Blind,Randomised Pragmatic Trial https://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1002/hep.510280507 Objective: Comparison of Octreotide with placebo in a treatment strategy for Early Rebleeding in Cirrhosis. P- 262 cirrhotic patients after control of acute upper digestive bleeding. I-131 patients were given a randomized, double blind trial of a 15-day course of subcutaneous octreotide vs placebo after control of upper digestive bleeding from any portal hypertensive source in cirrotic patients. C- Early rebleeding, from any source, within 15 days after randomization, was the primary measure of treatment. Secondary measure was the assessment of a 42-day rebleeding rate. O- Octreotide may safely reduce the risk of early rebleeding after upper digestive portal hypertensive hemorrhage in cirrhotic patients treated by Beta- blockers and/or sclerotherapy for long-...
Short case 1: A 70 year old Paddy farmer, came to OPD with c/o B/L pedal edema and shortness of breath since 6 months Pt was apparently asymptomatic 6 months back, then developed B/L pitting type of pedal edema upto thighs, facial puffiness, anasarca. Then he went to a private hospital in Hyderabad, during routine investigations was told to have elevated creatine levels and was told to undergo dialysis Pt then came to KIMS, NKP for further management. Pt has lost his livelihood since the last 6 months because he's been unable to work. He's survived by his wife and his son who lives elsewhere. He also has two daughters but they don't live with him. C/o B/L hip pain since 6 months No c/o decreased output of urine No h/o Fever, cough, cold In KIMS, KNO, pt underwent 10 sessions of dialysis 1st-8/12 2nd-11/12 3rd-15/12 4th-22/12 5th-27/12 6th-31/12 7th-8/1 8th-17/1 9th-22/1 10th-26/1 Patient is a k/c/o Hypertension and DM since 20 years, on regular medication. Started on i...
Attendance for the month of may. Medical leave- 0 Casual leave -0 May15th -followed morning rounds and discussed pathologist about BMD patient biopsy report and discharged the patient. 16th - opd duty 17th -attended daily rounds, evaluated the admitted patient (45yr Male 2 episodes of loose stools,RVD +ve with persistent diarrhoea) 18th - attended morning rounds and done all the investigations required for the patient. Prepared for case presentation. 19th -attended daily rounds, presented case and discussed relevant points. 20th -attended daily rounds, review usg done,fundoscopy of patient. 21st- attended daily rounds and helped in writing elog of BMD patient. 22nd - attended daily rounds,correction of hypokalemia to the patient and monitored.. 23rd - opd duty 24th - evaluated the case of 21yr Male with known case of type1 DM with high sugars and vomitings. 25th - attended rounds and done all the investigations required for the patient. 26th - attended ...
Comments
Post a Comment